Mounjaro®
Starting from £179.99/mo
Start journey Learn morePrivate Mounjaro prices in the UK vary by dose and provider, and 2026 looks different from 2025. Following Eli Lilly's list-price increase in September 2025, the highest-dose pen rose from around £122 to around £330 at list price, pushing typical private monthly costs across the market to roughly £149–£375 depending on dose and clinic. These are reported market figures, and your actual cost depends on which strength your prescriber deems appropriate, as well as what the quoted price actually covers. Mounjaro is a prescription-only medicine; a qualified prescriber must assess your suitability before any supply can lawfully take place, and the dose you start on is determined clinically, not by budget.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Eli Lilly's UK list-price revision, effective 1 September 2025, is the single biggest reason Mounjaro price comparisons for 2026 look so different from those you might have read a year earlier. The wholesale list price for a single high-dose pen rose from roughly £122 to roughly £330, and private providers absorbed or passed on that increase in different ways and at different speeds. If you want to understand whether Mounjaro has gone down in price since the revision, the short answer is that movement has been limited and highly provider-dependent. The September price change and its knock-on effects on private clinics are widely reported, and a dedicated look at how UK Mounjaro prices shifted across 2025 is worth reading before you compare quotes.
What this means practically: a 2.5mg starter pen sits at the lower end of that £149–£375 range, while 15mg pens (the highest licensed strength) sit at the top or above it. Starter-dose pricing and mid-range dose pricing follow different curves, so comparing a single headline figure across providers without specifying the dose is close to meaningless. NICE's appraisal of tirzepatide (TA1026, published December 2024) gives the clinical backdrop, including the eligibility thresholds that determine which dose a prescriber is likely to work toward.
One practical note: payday timing matters to a lot of people. Ordering on the first Monday of the month, or before a bank holiday, affects delivery windows, something worth checking when you plan your first order, because same-day dispatch requires approval before 12pm on a working day.
A quoted monthly figure from a provider often represents the pen itself and little else. Consultation fees, prescription charges, delivery costs and ongoing clinical support are commonly itemised separately or simply absent from the advertised number. That structure isn't dishonest, but it does mean a direct like-for-like comparison requires you to add up several line items rather than read a single price.
The categories worth checking before you compare: does the quoted price include the initial medical consultation, or is that a separate charge? Is the prescription fee bundled in? Is delivery free, and is it tracked? If your dose needs reviewing after three months, does a repeat consultation cost extra? For a prescription medicine taken weekly, those repeat touchpoints add up. A fuller breakdown of how Mounjaro pricing is structured across the market covers each of these components in more detail. The NHS England page on weight-management injections is also useful context for understanding what a complete clinical package should include, even in private settings.
There is also the question of what happens when things don't go smoothly. Gastrointestinal side effects are common in the early weeks of treatment; nausea, changes in digestion and reduced appetite are typical as the body adjusts. Having a clinical team available seven days a week when that happens is a different proposition from a service that processes prescriptions and leaves follow-up to a generic FAQ page.
Price is a reasonable starting point. It is a poor finishing point. For a prescription-only medicine, the question of whether you are getting the genuine, licensed product through a verified supply chain matters more than whether you saved £15 on a given month. The MHRA has issued repeated public warnings about counterfeit weight-loss pens circulating online, some have contained insulin rather than tirzepatide, and some sellers offer supply without any clinical assessment whatsoever. Reporting suspect sellers is possible via the MHRA's Yellow Card scheme. Verifying that a provider operates from a GPhC-registered pharmacy takes about thirty seconds on the GPhC register, and it is a step worth doing before handing over payment details to anyone.
A provider significantly below the £149 floor of typical market pricing is worth scrutinising carefully. A legitimate Mounjaro supply chain (genuine product, independent prescriber review, real pharmacy dispensing) has a cost floor that reflects those components. Prices far below that floor usually signal something missing: clinical oversight, supply-chain integrity, or both. For a much more detailed look at how prices across doses and providers compare, this overview of UK Mounjaro pricing goes through the numbers systematically.
At nume, we are a clinician-led service with a GPhC-registered pharmacy (registration 9012878). Our pricing is transparent and all-in, the price you see covers the consultation, prescription, treatment and next-working-day delivery, with 7-day aftercare built in. We do not run subscription models and every repeat order gets its own clinical review. That is not the cheapest offer on a comparison table. It is a deliberate choice. More about how we work is on our about page, and our clinical team is named and accountable. When you are ready to find out whether Mounjaro is clinically suitable for you, speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.